| 000 | 01652cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030606.0 | ||
| 008 | 120320s2012 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.19.05.M.Sc.2012.Ah.A | ||
| 100 | 0 | _aAhmed Elhussein Elsaied | |
| 245 | 1 | 0 |
_aAcute leukemia in children with down syndrome / _cAhmed Elhussein Elsaied ; Supervised Iman Abdelmokhales Sidhom , Heba Sayed Moussa , Yasser Elsayed Elborai |
| 246 | 1 | 5 | _aسرطان الدم الحاد فى أطفال متلازمة داون |
| 260 |
_aCairo : _bAhmed Elhussein Elsaied , _c2012 |
||
| 300 |
_a115 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Pediatric Oncology | ||
| 520 | _aDown syndrome has been recognized as one of the most important leukemia predisposing syndromes and patients with Down syndrome and leukemia have unique clinical features and significant differences in treatment response and toxicity profiles . One of the challenges faced in treating children with Down syndrome and leukemia is balancing curative therapy against potential toxicities | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAcute leukemia | |
| 653 | 4 | _aAn essay | |
| 653 | 4 | _aDown syndrome | |
| 700 | 0 |
_aHeba Sayed Moussa , _eSupervisor |
|
| 700 | 0 |
_aIman Abdelmokhales Sidhom , _eSupervisor |
|
| 700 | 0 |
_aYasser Elsayed Elborai , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c37925 _d37925 |
||